Xydalba – A full treatment course in one 30 minute infusion duplicate
Xydalba is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults1.
Dr. John Cunniffe explains the benefits of Xydalba
The content of this website has been developed for UK healthcare professionals only.
This medicinal product is subject to additional monitoring.
Xydalba is contraindicated in patients hypersensitive to the active substance or to any of the excipients (mannitol {E421}, lactose monohydrate, hydrochloric acid and sodium hydroxide {pH adjusters}).1
Prescribing-only medicine.
1. Xydalba SmPC
Item code: XYUK26032019WS
Date of preparation: March 2019